Bayer appoints Juan Farinati CEO for the Southern Cone, effective 1 November
Bayer nombra a Juan Farinati Gerente General para el Cono Sur, a contar desde el 1 de noviembre
Intel ID : 331085
|
||||
| Intel ID | 331085 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
|
Financial Data - Bayer
(31 Dec 2013) |
Revenue: - EBITDA: - |
|
| Date |
|
|
| Country |  |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Target
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Secondary Sectors (TTRSC) |
30.01.04 Specialty Pharmaceuticals 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals 55.02.04 Pharmaceutical & Personal Care Chemicals 55 Raw Materials & Natural Resources / 55.02 Chemicals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.